Rana Abdat, MD
Dermatology · Nashua, NHNPI 1447784673
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $524 of the $720 with a category attached, or 72.8%. 7 manufacturers reported payments, led by Johnson & Johnson at 24.9% of the total. Reporting peaked in 2024 at $288 and has fallen 65.6% since, to $99 in 2025. That places this record below the midpoint for dermatology clinicians in NH, where the typical reported total is $720.
Across 14 payments — averaging $51.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$179
- Pfizer$152
- AbbVie$150
- Incyte Corporation$109
- Boehringer Ingelheim$51
- Novartis$40
- plus $39 from 1 others
What the payments were for
- Food & beverage$52473%
- Education$19627%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 2 | $179 |
| Pfizer | 3 | $152 |
| AbbVie | 4 | $150 |
| Incyte Corporation | 2 | $109 |
| Boehringer Ingelheim | 1 | $51 |
| Novartis | 1 | $40 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CIBINQO$135
How this compares
$720 in reported general payments places this provider in the 50th percentile of 75 dermatology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 48 | $2,496 |
| Halobetasol Propionate | 34 | $1,585 |
| Ketoconazole | 87 | $1,166 |
| Metronidazole | 22 | $1,066 |
| Fluorouracil | 13 | $893 |
| Betamethasone Dipropionate | 17 | $738 |
| Clindamycin Phosphate | 21 | $582 |
| Nystatin | 31 | $527 |
| Fluocinonide | 15 | $507 |
| NyamycNystatin | 14 | $455 |
| Econazole Nitrate | 26 | $423 |
| Triamcinolone Acetonide | 74 | $393 |
| Doxycycline Hyclate | 19 | $364 |
| Hydrocortisone | 66 | $290 |
| Mupirocin | 18 | $78 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Nashua
- Robert PosnickNashua$951K
- David PosnickNashua$203K
- Michael LichterNashua$53K
- Christopher MancusoNashua$22K
- Stephen MoyerNashua$3K
- Abdulaziz AlomranNashua$369
- Elizabeth LesterNashua$78
- Abel JarellPortsmouth$2.3M
- Yulianna RussakLebanon$170K
- Peter JenkinManchester$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.